PD4PD:Partnered Dance for Parkinson Disease

This study has been completed.
Sponsor:
Collaborator:
Parkinson's Disease Foundation
Information provided by:
Washington University School of Medicine
ClinicalTrials.gov Identifier:
NCT01388556
First received: June 29, 2011
Last updated: July 5, 2011
Last verified: July 2011
  Purpose

Exercise is often noted as an important component in a comprehensive approach to the management of Parkinson disease (PD). Most studies of exercise have examined the effects of short-term interventions and have tested participants on their anti-Parkinson medications. As such, these studies have not been able to determine whether or not exercise may have a disease-modifying effect in people with PD. The investigators recent work has shown the potential benefits of dance as a form of exercise for individuals with PD, but, like previous work, has only examined short-term interventions. The investigators think that dance may be ideally suited for study over a longer period of time because dance incorporates many of the features recommended for inclusion in PD-specific exercise programs in a format that is known to be engaging and to enhance motivation to participate in healthful behaviors. As such, the investigators aim to determine both the short- and long-term effectiveness of a community-based dance program for individuals with Parkinson disease and to determine how physical function changes over time in individuals with PD who do not exercise as compared to those who exercise regularly. The investigators hypothesize that:

A) participation in dance will result in improved physical function, cognitive function, mood and quality of life in people with PD within 3 months,

B) additional improvements will be noted at 6 months as compared to 3 months,

C) improvements will be maintained at one year with continued, regular participation in a dance class,

D) those who do not exercise will show significant functional decline over a period of one year, a decline that will not be present in those who dance regularly.


Condition Intervention Phase
Parkinson Disease
Behavioral: Tango dancing
Phase 2
Phase 3

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Single Blind (Outcomes Assessor)
Primary Purpose: Treatment
Official Title: PD4PD:Partnered Dance for Parkinson Disease

Resource links provided by NLM:


Further study details as provided by Washington University School of Medicine:

Primary Outcome Measures:
  • Motor Symptom Severity [ Time Frame: 12 months ] [ Designated as safety issue: No ]
    We will use the Unified Parkinson Disease Rating Scale, Motor Subscale 3, to assess the severity of movement-related symptoms. This is a standanrdized and well-established tool composed of multiple items each scored on a 0-4 scale, with 0 indicating no impairment and 4 indication severe impairment. The overall severity of motor symptoms is determined by summing scores for all of the individual items.


Enrollment: 62
Study Start Date: July 2009
Study Completion Date: June 2011
Primary Completion Date: June 2011 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Tango
Twice weekly tango dance classes for 12 months.
Behavioral: Tango dancing
Twice weekly tango dance classes
No Intervention: Control Group

  Eligibility

Ages Eligible for Study:   30 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • normal central and peripheral neurological function
  • at least grade 4/5 strength and normal joint ranges of motion in both legs, - vision corrected to 20/40 or better
  • able to walk independently for 10 feet with or without an assistive device, - normal somatosensory function in the feet (2-point discrimination, vibration, joint kinesthesia, and light touch)
  • no history of vestibular disease

Exclusion Criteria:

  • serious medical problem
  • evidence of abnormality other than PD-related changes on brain imaging (previously done for clinical evaluations-not part of this research)
  • history or evidence of neurological deficit other than PD that could interfere, such as previous stroke or muscle disease
  • history or evidence of orthopedic, muscular, or psychological problem
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01388556

Locations
United States, Missouri
Washington University School of Medicine
St. Louis, Missouri, United States, 63108
Sponsors and Collaborators
Washington University School of Medicine
Parkinson's Disease Foundation
  More Information

Publications:
Responsible Party: Gammon Earhart, PhD, PT, Associate Professor, Washington University in St. Louis
ClinicalTrials.gov Identifier: NCT01388556     History of Changes
Other Study ID Numbers: PD4PD-09-0168, PDF
Study First Received: June 29, 2011
Last Updated: July 5, 2011
Health Authority: United States: Institutional Review Board

Keywords provided by Washington University School of Medicine:
exercise
Parkinson disease
motor symptoms
gait
balance

Additional relevant MeSH terms:
Parkinson Disease
Parkinsonian Disorders
Basal Ganglia Diseases
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases
Movement Disorders
Neurodegenerative Diseases

ClinicalTrials.gov processed this record on July 29, 2014